Terminated PHASE1 INTERVENTIONAL 2-arm NCT06607484

Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878

Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of SR-878 in Healthy Volunteers

Sponsor: SciRhom GmbH

Conditions Healthy Volunteers

Interventions Placebo SR-878

Updated 3 times since 2024 Last updated: May 28, 2025 Started: Oct 8, 2024 Primary completion: Feb 27, 2025 Completion: Feb 27, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other Healthy Volunteers trials with similar outcome

Browse all Healthy Volunteers trials

Listed as NCT06607484, this PHASE1 trial focuses on Healthy Volunteers and remains terminated or withdrawn. Sponsored by SciRhom GmbH, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Jun 2025 — Present [monthly]

Terminated PHASE1

Status: Recruiting → Terminated
Dec 2024 — Jun 2025 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Oct 2024 — Dec 2024 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SciRhom GmbH

Data source: SciRhom GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria